Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;51(3):711-719.
doi: 10.1007/s11239-020-02346-7. Epub 2020 Nov 28.

A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?

Claire Pluchart  1   2   3 , Coralie Barbe  4 , Gael Poitevin  5 , Sandra Audonnet  6 , Philippe Nguyen  5   7
Affiliations

A pilot study of procoagulant platelet extracellular vesicles and P-selectin increase during induction treatment in acute lymphoblastic leukaemia paediatric patients: two new biomarkers of thrombogenic risk?

Claire Pluchart et al. J Thromb Thrombolysis. 2021 Apr.

Abstract

In paediatric acute lymphoblastic leukaemia (ALL), focus has shifted towards preventing treatment-related complications, including venous thromboembolism, the cause of significant mortality and morbidity. To better understand thrombogenic mechanisms during induction treatment, we studied the number, origin and procoagulant activity of extracellular vesicles (EVs) and P-selectin level throughout the induction course in 24 paediatric patients. EVs were mainly of platelet origin. We observed a significant increase in EV number, in platelet EV number and P-selectin level throughout the induction course. There was a correlation between higher EV and platelet EV number, P-selectin level, higher platelet count and leucocyte count. We also observed a correlation between higher EV procoagulant activity and higher platelet count and leucocyte count and higher P-selectin level. Older age and T phenotype were associated with a higher EV procoagulant activity. Platelet EV generation may play a role in thrombogenic complications in ALL patients and could serve as a biomarker to identify patients with a high risk of thrombosis. As a marker of platelet activation, P-selectin may be another relevant marker with the advantage of being easier to analyse in clinical practice.

Keywords: Acute lymphoblastic leukaemia; Extracellular vesicles; Platelets; Venous thromboembolism.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Pui C-H, Yang JJ, Hunger SP et al (2015) Childhood acute lymphoblastic leukemia: progress through collaboration. JCO 33:2938–2948. https://doi.org/10.1200/JCO.2014.59.1636 - DOI
    1. Mondelaers V, Suciu S, De Moerloose B et al (2017) Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951. Haematologica 102:1727–1738. https://doi.org/10.3324/haematol.2017.165845 - DOI - PubMed - PMC
    1. Tuckuviene R, Ranta S, Albertsen BK et al (2016) Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study. J Thromb Haemost 14:485–494. https://doi.org/10.1111/jth.13236 - DOI - PubMed
    1. Hough R, Vora A (2017) Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment). Hematology Am Soc Hematol Educ Program 2017:251–258. https://doi.org/10.1182/asheducation-2017.1.251 - DOI - PubMed - PMC
    1. Levy-Mendelovich S, Barg AA, Kenet G (2018) Thrombosis in pediatric patients with leukemia. Thromb Res 164(Suppl 1):S94–S97. https://doi.org/10.1016/j.thromres.2018.01.019 - DOI - PubMed

MeSH terms

LinkOut - more resources